• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.69% Nasdaq Up0.44%

    Acorda Therapeutics, Inc. (ACOR)

    -NasdaqGS
    33.78 Down 0.83(2.40%) 4:00PM EDT
    |After Hours : 33.78 0.00 (0.00%) 4:17PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 401,480   336,430   305,814  
    Cost of Revenue80,615  66,643  57,641  
    Gross Profit 320,865   269,787   248,173  
    Operating Expenses
    Research Development73,470  53,877  53,881  
    Selling General and Administrative204,013  185,545  168,690  
    Non Recurring6,991   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 36,391   30,365   25,602  
    Income from Continuing Operations
    Total Other Income/Expenses Net906  668  546  
    Earnings Before Interest And Taxes37,297  31,033  26,148  
    Interest Expense9,288  2,170  1,880  
    Income Before Tax28,009  28,863  24,268  
    Income Tax Expense10,337  12,422  (130,690)
    Minority Interest -   -   -  
    Net Income From Continuing Ops17,672  16,441  154,958  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 17,672   16,441   154,958  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 17,672   16,441   154,958  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.